Trial watch: chemotherapy-induced immunogenic cell death in oncology

J Sprooten, RS Laureano, I Vanmeerbeek… - …, 2023 - Taylor & Francis
Immunogenic cell death (ICD) refers to an immunologically distinct process of regulated cell
death that activates, rather than suppresses, innate and adaptive immune responses. Such …

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer

RS Laureano, J Sprooten, I Vanmeerbeerk… - …, 2022 - Taylor & Francis
Dendritic cell (DC)-based vaccination for cancer treatment has seen considerable
development over recent decades. However, this field is currently in a state of flux toward …

[HTML][HTML] The interface of tumour-associated macrophages with dying cancer cells in immuno-oncology

I Vanmeerbeek, J Govaerts, RS Laureano, J Sprooten… - Cells, 2022 - mdpi.com
Tumour-associated macrophages (TAMs) are essential players in the tumour
microenvironment (TME) and modulate various pro-tumorigenic functions such as …

Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines

M Hensler, J Rakova, L Kasikova, T Lanickova… - …, 2022 - Taylor & Francis
Dendritic cells (DCs) have received considerable attention as potential targets for the
development of novel cancer immunotherapies. However, the clinical efficacy of DC-based …

Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer

Y Lambrechts, AD Garg, G Floris, K Punie, P Neven… - Genes & …, 2023 - nature.com
There is an urgent need for new and better biomarker modalities to estimate the risk of
recurrence within the luminal-like breast cancer (BC) population. Molecular diagnostic tests …

Dissection of molecular determinants of metastasis and detailed characterization of the age-related immunological profile in (older) patients with hormone-sensitive …

Y Lambrechts, H Wildiers, G Floris, S Hatse - 2023 - lirias.kuleuven.be
This PhD project's main objective is to better understand and characterize the tumor biology
and immunology of HR+/HER2-breast cancer in (older) patients. First, we want to improve …